← Leaderboards
Xin Yuan
Beth Israel Deaconess Medical Center
$3,922,786
Attributed
$5,408,787
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $395.5K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,408,787 · 4
By mechanism
R01$4,762,812 · 3
K01$645,975 · 1
Top collaborators
- Steven P. Balk8 shared
Others in their field
Top investigators on “Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$257,543,614
- Charles A Coltman · Southwest Oncology Group$181,133,593
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Larry Arthur$62,719,328
- William J. Blot · Vanderbilt University$62,640,427
- Walter John Curran · Thomas Jefferson University$60,981,384
Research focus
ProstateMolecularMalignant Neoplasm Of ProstateGrowthTranscription FactorResponseTumorSignal PathwayPathway InteractionsAndrogensSamplingCellsSignal TransductionMaintenanceGenesMalignant NeoplasmsSiteDoxycyclineProductionAdultGene TargetingFetalAngiogenesisProteins
Grant awards (18)
WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer$395,509
R01 · FY2025 · CA
WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer$375,734
R01 · FY2024 · CA
WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer$395,509
R01 · FY2023 · CA
SOX9 Mediation of AR and ERG Driven Prostate Cancer$361,050
R01 · FY2018 · CA
SOX9 Mediation of AR and ERG Driven Prostate Cancer$361,050
R01 · FY2017 · CA
SOX9 Mediation of AR and ERG Driven Prostate Cancer$361,050
R01 · FY2016 · CA
SOX9 Mediation of AR and ERG Driven Prostate Cancer$361,050
R01 · FY2015 · CA
SOX9 Mediation of AR and ERG Driven Prostate Cancer$361,050
R01 · FY2014 · CA
SOX9 in prostate cancer development and progression$354,061
R01 · FY2012 · DK · contact PI
SOX9 in prostate cancer development and progression$354,061
R01 · FY2011 · DK · contact PI
SOX9 in prostate cancer development and progression$360,188
R01 · FY2010 · DK · contact PI
SOX9 in prostate cancer development and progression$361,250
R01 · FY2009 · DK · contact PI
SOX9 in prostate cancer development and progression$361,250
R01 · FY2008 · DK · contact PI
Androgen Receptor and SRY/SOX Interaction in Prostate$128,979
K01 · FY2007 · DK · contact PI
Androgen Receptor and SRY/SOX Interaction in Prostate$128,979
K01 · FY2006 · DK · contact PI
Androgen Receptor and SRY/SOX Interaction in Prostate$130,059
K01 · FY2005 · DK
Androgen Receptor and SRY/SOX Interaction in Prostate$128,979
K01 · FY2004 · DK
Androgen Receptor and SRY/SOX Interaction in Prostate$128,979
K01 · FY2003 · DK